Continuous tissue glucose monitoring correlates with measurement of intermittent capillary glucose in patients with distributive shock

Ballesteros, Daniel; Martínez, Óscar; Gómez-Casero, R. Blancas; Parra, C. Martín; Matamala, B. López; Estébanez, Belen; Chana, M.

doi:10.1016/j.medine.2015.09.001

Cited by 3 publications

(3 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients with septic shock and on insulin infusion, CGM (Medtronic MiniMed Soft-Sensor™) correlates with intermittent capillary blood glucose measurements. 84 Other RCTs (randomized controlled trials) have yielded same correlation between POC glucose measurements and CGM in ICU patients. 85 The literature is mixed in regards to CGM and detection of hypoglycemia, while Holzinger et al showed that CGM decrease the episodes of hypoglycemia, 86 Boom et al failed to demonstrate increase detection of hypoglycemic events.…”

Section: Continuous Glucose Monitoring (Cgm)mentioning

confidence: 87%

Glucose Management Technologies for the Critically Ill

Salinas

Mendez

2019

J Diabetes Sci Technol

View full text Add to dashboard Cite

Hyperglycemia is common in the intensive care unit (ICU) both in patients with and without a previous diagnosis of diabetes. The optimal glucose range in the ICU population is still a matter of debate. Given the risk of hypoglycemia associated with intensive insulin therapy, current recommendations include treating hyperglycemia after two consecutive glucose >180 mg/dL with target levels of 140-180 mg/dL for most patients. The optimal method of sampling glucose and delivery of insulin in critically ill patients remains elusive. While point of care glucose meters are not consistently accurate and have to be used with caution, continuous glucose monitoring (CGM) is not standard of care, nor is it generally recommended for inpatient use. Intravenous insulin therapy using paper or electronic protocols remains the preferred approach for critically ill patients. The advent of new technologies, such as electronic glucose management, CGM, and closed-loop systems, promises to improve inpatient glycemic control in the critically ill with lower rates of hypoglycemia.

show abstract

Section: Continuous Glucose Monitoring (Cgm)mentioning

confidence: 87%

Glucose Management Technologies for the Critically Ill

Salinas

Mendez

2019

J Diabetes Sci Technol

View full text Add to dashboard Cite

show abstract

“…This review excluded studies evaluating CGM accuracy and reliability, which have been reviewed previously. [23][24][25][26][27][28][29][30][31] While we reference isolated inpatient non-ICU CGM cases, we primarily included observational and randomized CGM glycemic outcome studies in this review (six ICU studies, three non-ICU studies), reflecting the scarcity of evidence on this topic, and the need for further studies.…”

Section: Search Methodsmentioning

confidence: 99%

“…As of 2011, the Endocrine Society recommended against inpatient CGM due to lack of published safety and efficacy data. 22 Since that time, numerous publications have evaluated inpatient CGM accuracy, reliability, and safety; [23][24][25][26][27][28][29][30][31] however, few studies have evaluated the glycemic outcomes of subcutaneous CGM, which are limited by the lack of Type 1 Diabetes Mellitus (T1DM) subjects and the use of different CGM systems. This article will review subcutaneous CGM glycemic outcomes in the adult ICU and non-ICU setting.…”

Section: Review Articlementioning

confidence: 99%

Inpatient Continuous Glucose Monitoring and Glycemic Outcomes

Levitt

Silver

Spanakis

2017

J Diabetes Sci Technol

View full text Add to dashboard Cite

Continuous glucose monitoring (CGM) is commonly used in the outpatient setting to improve diabetes management. CGM can provide real-time glucose trends, detecting hyperglycemia and hypoglycemia before the onset of clinical symptoms. In 2011, at the time the Endocrine Society CGM guidelines were published, the society did not recommend inpatient CGM as its efficacy and safety were unknown. While many studies have subsequently evaluated inpatient CGM accuracy and reliability, glycemic outcome studies have not been widely published. In the non-ICU setting, investigational CGM studies have commonly blinded providers and patients to glucose data. Retrospective review of the glucose data reflects increased hypoglycemia detection with CGM. In the ICU setting, data are inconsistent whether CGM can improve glycemic outcomes. Studies have not focused on hospitalized patients with type 1 diabetes mellitus, the population most likely to benefit from inpatient CGM. This article reviews inpatient CGM glycemic outcomes in the non-ICU and ICU setting.

show abstract

Continuous Glucose Monitoring in the Hospital

et al. 2021

View full text Add to dashboard Cite

Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatically and remotely supplement or replace assisted monitoring of blood glucose by bedside nurses can decrease: the amount of necessary nursing exposure to COVID-19 patients with diabetes; the amount of time required for obtaining blood glucose measurements, and the amount of personal protective equipment necessary for interacting with patients during the blood glucose testing. The United States Food and Drug Administration (FDA) is now exercising enforcement discretion and not objecting to certain factory-calibrated CGMs being used in a hospital setting, both to facilitate patient care and to obtain performance data that can be used for future regulatory submissions. CGMs can be used in the hospital to decrease the frequency of fingerstick point of care capillary blood glucose testing, decrease hyperglycemic episodes, and decrease hypoglycemic episodes. Most of the research on CGMs in the hospital has focused on their accuracy and only recently outcomes data has been reported. A hospital CGM program requires cooperation of physicians, bedside nurses, diabetes educators, and hospital administrators to appropriately select and manage patients. Processes for collecting, reviewing, storing, and responding to CGM data must be established for such a program to be successful. CGM technology is advancing and we expect that CGMs will be increasingly used in the hospital for patients with diabetes.

show abstract

Continuous tissue glucose monitoring correlates with measurement of intermittent capillary glucose in patients with distributive shock

Cited by 3 publications

References 35 publications

Glucose Management Technologies for the Critically Ill

Glucose Management Technologies for the Critically Ill

Inpatient Continuous Glucose Monitoring and Glycemic Outcomes

Continuous Glucose Monitoring in the Hospital

Contact Info

Product

Resources

About